Report on the risk assessment of 1-(3-chlorophenyl)-2-(methylamino)propan-1-one (3-chloromethcathinone, 3-CMC) in accordance with Article 5c of Regulation (EC) No 1920/2006 (as amended) 17. March 2022, section EUDA news
5. June 2026 Help us shape EUDA Strategy 2030: public consultation opens today! Today, the European Union Drugs Agency (EUDA) launches a public consultation to help shape its forthcoming Strategy 2030. The...